ADC Therapeutics SA at Morgan Stanley Global Healthcare Conference Transcript
Good morning, afternoon. It's still morning, right? Good morning, everybody, almost afternoon. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have ADC Therapeutics with us for the next session.
Quickly before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. So with that, pleased to have Ameet Mallik, who's the CEO at ADC.
Questions & Answers
Maybe just a nice place to start is you joined a couple of months ago, I guess, at this point. Maybe just talk to us about why you joined? Why you think it's an interesting opportunity and what you're looking forward to?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |